Decide at what price you'd be comfortable buying and we'll help you stay ready.
Ionis Pharmaceuticals is a drug company that makes medicines based on antisense technology, a way to turn off harmful proteins by targeting RNA before they are made. It spends most of its effort on discovering and developing treatments for serious diseases, especially rare genetic, neurological, cardiovascular, and metabolic conditions. Its pipeline is the main business asset: it creates drug candidates and then tests them through clinical development.
Ionis usually makes money in two ways. It earns partnership income when larger pharmaceutical companies help fund development or commercialize a medicine, and it can also collect royalties, milestones, and, for some products, sales revenue. That means it is not a broad drug seller with many large in-house brands; it is more of a specialist research company that turns RNA science into medicines and often shares the later stages of development and marketing with partners.
What makes Ionis different is its focus on antisense drugs, which can be designed to hit very specific disease targets. This gives it a clear role in the biotech value chain: it invents and advances the science, while partners often help with large-scale clinical trials, manufacturing, and sales. For investors, the business is easiest to think of as a research-driven platform company that aims to convert a steady stream of new drug ideas into licensing deals and marketed therapies.
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more